These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 22293522)
21. Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site. Yoshida N; Terukina S; Okuma M; Moroi M; Aoki N; Matsuda M J Biol Chem; 1988 Sep; 263(27):13848-56. PubMed ID: 2971046 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and characterization of a bioactive 82-residue sphingolipid activator protein, saposin C. Weiler S; Carson W; Lee Y; Teplow DB; Kishimoto Y; O'Brien JS; Barranger JA; Tomich JM J Mol Neurosci; 1993; 4(3):161-72. PubMed ID: 8292489 [TBL] [Abstract][Full Text] [Related]
24. The effects of a histidine residue on the C-terminal side of an asparaginyl residue on the rate of deamidation using model pentapeptides. Goolcharran C; Stauffer LL; Cleland JL; Borchardt RT J Pharm Sci; 2000 Jun; 89(6):818-25. PubMed ID: 10824141 [TBL] [Abstract][Full Text] [Related]
25. Identification and determination of structurally related peptide impurities in thymalfasin by liquid chromatography-high-resolution mass spectrometry. Cheng Y; Wu P; Kan Y; Li M; Li H Anal Bioanal Chem; 2022 Nov; 414(28):8035-8045. PubMed ID: 36207535 [TBL] [Abstract][Full Text] [Related]
26. Betaseron. Lin L Dev Biol Stand; 1998; 96():97-104. PubMed ID: 9890522 [TBL] [Abstract][Full Text] [Related]
27. Degradation of aspartic acid and asparagine residues in human growth hormone-releasing factor. Bongers J; Heimer EP; Lambros T; Pan YC; Campbell RM; Felix AM Int J Pept Protein Res; 1992 Apr; 39(4):364-74. PubMed ID: 1428526 [TBL] [Abstract][Full Text] [Related]
28. Characterization of the deamidated forms of recombinant hirudin. Tuong A; Maftouh M; Ponthus C; Whitechurch O; Roitsch C; Picard C Biochemistry; 1992 Sep; 31(35):8291-9. PubMed ID: 1525166 [TBL] [Abstract][Full Text] [Related]
29. Identification of active-site peptides from 3H-labeled 2-ethynylnaphthalene-inactivated P450 2B1 and 2B4 using amino acid sequencing and mass spectrometry. Roberts ES; Hopkins NE; Zaluzec EJ; Gage DA; Alworth WL; Hollenberg PF Biochemistry; 1994 Mar; 33(12):3766-71. PubMed ID: 8142377 [TBL] [Abstract][Full Text] [Related]
31. Deamidation at asparagine-88 in recombinant human interleukin 2. Sasaoki K; Hiroshima T; Kusumoto S; Nishi K Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):976-80. PubMed ID: 1525954 [TBL] [Abstract][Full Text] [Related]
32. Chemical pathways of peptide degradation. III. Effect of primary sequence on the pathways of deamidation of asparaginyl residues in hexapeptides. Patel K; Borchardt RT Pharm Res; 1990 Aug; 7(8):787-93. PubMed ID: 2235875 [TBL] [Abstract][Full Text] [Related]
33. Assessment method for deamidation in proteins using carboxylic acid derivatization-liquid chromatography-tandem mass spectrometry. Kawasue S; Sakaguchi Y; Koga R; Yoshida H; Nohta H J Pharm Biomed Anal; 2020 Mar; 181():113095. PubMed ID: 31962249 [TBL] [Abstract][Full Text] [Related]
34. Beta-endorphin-related peptides in the human pituitary. Isolation and characterization of major immunoreactive peptides, including the formerly unrecognized peptide beta-endorphin 1-18. Vuolteenaho O Acta Physiol Scand Suppl; 1984; 531():1-84. PubMed ID: 6091413 [TBL] [Abstract][Full Text] [Related]
35. Selective deamidation of recombinant human stem cell factor during in vitro aging: isolation and characterization of the aspartyl and isoaspartyl homodimers and heterodimers. Hsu YR; Chang WC; Mendiaz EA; Hara S; Chow DT; Mann MB; Langley KE; Lu HS Biochemistry; 1998 Feb; 37(8):2251-62. PubMed ID: 9485371 [TBL] [Abstract][Full Text] [Related]
36. Isolation and identification of cyclic imide and deamidation products in heat stressed pramlintide injection drug product. Hekman CM; DeMond WS; Kelley PJ; Mauch SF; Williams JD J Pharm Biomed Anal; 1999 Sep; 20(5):763-72. PubMed ID: 10701984 [TBL] [Abstract][Full Text] [Related]
37. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products. Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957 [TBL] [Abstract][Full Text] [Related]
38. Transition-metal complexes as enzyme-like reagents for protein cleavage: complex cis-[Pt(en)(H2O)2]2+ as a new methionine-specific protease. Milović NM; Dutca LM; Kostić NM Chemistry; 2003 Oct; 9(20):5097-106. PubMed ID: 14562327 [TBL] [Abstract][Full Text] [Related]
39. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. Geiger T; Clarke S J Biol Chem; 1987 Jan; 262(2):785-94. PubMed ID: 3805008 [TBL] [Abstract][Full Text] [Related]
40. Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension. Chunxiao W; Jingjing L; Yire X; Min D; Zhaohui W; Gaofu Q; Xiangchun S; Xuejun W; Jie W; Taiming L Regul Pept; 2007 Jun; 141(1-3):35-43. PubMed ID: 17300845 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]